What is the NOAEL for Butyl propionate?
Butyl propionate has 30 NOAEL studies in the database. The lowest reported value is 0 % via Dermal in Human. Source: NTP ICE skin sensitization.
Also known as: Propanoic acid, butyl ester, 4-02-00-00708, BRN 1700932, Butyl propanoate, n-Butyl propanoate (+10 more)
CAS 590-01-2
Butyl propionate (CAS 590-01-2) is a chemical substance. Key regulatory status: REACH registered, 12 regulatory/inventory lists, cosmetic ingredient cross-reference; source data from EPA ToxValDB, EPA CPDat, AICIS, ECHA REACH, ILO ICSC.
CAS, identifiers, formula, and alternate names for the matched substance record.
International Chemical Safety Card hazard and exposure summary.
| Field | Value |
|---|---|
| Short-term Effects | The vapour is irritating to the respiratory tract. |
| Routes of Exposure | The substance can be absorbed into the body by inhalation. |
Industrial and product-use categories associated with this substance.
Inventory, screening, and regulatory list matches from public chemical databases.
| List | Keyword | Source |
|---|---|---|
| IFRA Transparency | IFRA | IFRA |
| Europe | European Commission | Fl@vis |
| food_additive; Substances Added to Food (formerly EAFUS) (2/2019) | FDA | United States Food and Drug Administration (FDA) |
| consumer_product | P&G | Proctor & Gamble |
| air; detected; emissions; Europe; Other direct contact consumer goods | Danish Environmental Protection Agency | Danish EPA |
| air; emissions; Europe; nondetect; Other direct contact consumer goods | Danish Environmental Protection Agency | Danish EPA |
| Arts and crafts/Office supplies - fabric treatment and dye; detected | Danish Environmental Protection Agency | Danish EPA |
| air; detected; emissions; Europe; Other direct contact consumer goods | Danish Environmental Protection Agency | Danish EPA |
| IFRA Transparency | IFRA | IFRA |
| Europe | European Commission | Fl@vis |
| food_additive; Substances Added to Food (formerly EAFUS) (2/2019) | FDA | United States Food and Drug Administration (FDA) |
| consumer_product | P&G | Proctor & Gamble |
Toxicology endpoints rendered from public NOAEL study rows.
| Value | Unit | Endpoint | Route | Species | Source |
|---|---|---|---|---|---|
| =64 | mg/m3 | DNEL local | inhalation | Human | ToxValDB GESTIS DNEL |
| 33.8 | min | ET50 | Dermal | - | NTP ICE skin irritation |
| 2NXC4AK99E | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| 0 | % | Incidence of positive responses | Dermal | Human | NTP ICE skin sensitization |
| 1350 | ug/cm2 | Induction dose per skin area | Dermal | Human | NTP ICE skin sensitization |
| >23.78 | mg/L | LC50 | Inhalation | - | NTP ICE acute inhalation |
| =3993 | mg/m3 | LOAEL | inhalation | Rat | ToxValDB HPVIS |
| =4260 | mg/m3 | LOAEL | inhalation | Rat | ToxValDB HPVIS |
| =1.331e+4 | mg/m3 | LOAEL | inhalation | Rat | ToxValDB HPVIS |
| =1331 | mg/m3 | NOAEL | inhalation | Rat | ToxValDB HPVIS |
| =2662 | mg/m3 | NOAEL | inhalation | Rat | ToxValDB HPVIS |
| =7987 | mg/m3 | NOAEL | inhalation | Rat | ToxValDB HPVIS |
| >=1.065e+4 | mg/m3 | NOAEL | inhalation | Rat | ToxValDB HPVIS |
| 3 | unitless | Relative reliability score | Dermal | Human | NTP ICE skin sensitization |
| 31.52 | % | Viability | Dermal | - | NTP ICE skin irritation |
| 95.6 | % | Viability | Dermal | - | NTP ICE skin irritation |
| 97.9 | % | Viability | Dermal | - | NTP ICE skin irritation |
| 107.7 | % | Viability | Dermal | - | NTP ICE skin irritation |
| 132.5 | % | Viability | Dermal | - | NTP ICE skin irritation |
| 83.7 | % | Viability (18 hours) | Dermal | - | NTP ICE skin irritation |
| 47.9 | % | Viability (240 minutes) | Dermal | - | NTP ICE skin irritation |
| 58.7 | % | Viability (240 minutes) | Dermal | - | NTP ICE skin irritation |
| 63.1 | % | Viability (240 minutes) | Dermal | - | NTP ICE skin irritation |
| 95.3 | % | Viability (3 minutes) | Dermal | - | NTP ICE skin irritation |
| 106.3 | % | Viability (3 minutes) | Dermal | - | NTP ICE skin irritation |
| 111.5 | % | Viability (3 minutes) | Dermal | - | NTP ICE skin irritation |
| 83.6 | % | Viability (42 hours) | Dermal | - | NTP ICE skin irritation |
| 70.4 | % | Viability (60 minutes) | Dermal | - | NTP ICE skin irritation |
| 80.5 | % | Viability (60 minutes) | Dermal | - | NTP ICE skin irritation |
| 105.7 | % | Viability (60 minutes) | Dermal | - | NTP ICE skin irritation |
Showing 30 of 30 studies
Registration status from the ECHA REACH registered substances database.
| Status | Name | EC Number | Link |
|---|---|---|---|
| Registered | Butyl propionate | 209-669-5 | ECHA overview → |
Australian industrial chemicals inventory status and applicable conditions.
Same-CAS cosmetic ingredient record for cross-vertical context.
Same-CAS pharmaceutical records from drug and bioactivity sources.
Butyl propionate has 30 NOAEL studies in the database. The lowest reported value is 0 % via Dermal in Human. Source: NTP ICE skin sensitization.
Butyl propionate appears on 7 regulatory/inventory lists including IFRA Transparency, Europe, food_additive; Substances Added to Food (formerly EAFUS) (2/2019), and 4 more. Source: EPA CPDat.
Yes, Butyl propionate is also indexed as a cosmetic ingredient under the name Butyl Propionate. View the full cosmetic safety profile on the ingredient page for detailed safety data, SCCS opinions, and regulatory status.
Safety data is sourced from EPA ToxValDB, EPA CPDat, AICIS (Australian Industrial Chemicals Introduction Scheme), EPA DSSTox, ECHA REACH, ILO/WHO ICSC, CosIng / Ingredients DB, ChEMBL / DailyMed. All data traces to primary regulatory sources and is updated from official government databases.
Butyl propionate also appears in cosmetics, pharmaceutical databases.